International Business Machines (IBM) is down 4.2% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely explanation is a mix of company-specific caution and a weaker tape for large technology names. The catalyst does not appear to be a fresh negative filing or earnings release today, so this could be because investors are still reacting to concerns about IBM’s growth outlook and the durability of its recent software momentum while the broader market sells off.
Details:
Sources:
IBM Newsroom, Reuters, AP News
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$IBM Insider Trading Activity
$IBM insiders have traded $IBM stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $IBM stock by insiders over the last 6 months:
- ROBERT DAVID THOMAS (Senior Vice President) sold 25,000 shares for an estimated $5,758,087
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$IBM Hedge Fund Activity
We have seen 1,636 institutional investors add shares of $IBM stock to their portfolio, and 1,879 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM removed 399,120,537 shares (-99.7%) from their portfolio in Q3 2026, for an estimated $87,778,579,702
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. removed 7,132,137 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $1,568,570,890
- CAPITAL WORLD INVESTORS removed 5,268,899 shares (-32.5%) from their portfolio in Q3 2026, for an estimated $1,158,788,957
- WELLINGTON MANAGEMENT GROUP LLP removed 4,130,523 shares (-63.1%) from their portfolio in Q3 2026, for an estimated $908,425,923
- ASCENTIS WEALTH MANAGEMENT, LLC removed 3,213,888 shares (-99.7%) from their portfolio in Q3 2026, for an estimated $706,830,387
- FMR LLC removed 3,201,178 shares (-43.1%) from their portfolio in Q3 2026, for an estimated $704,035,077
- CAPITAL WEALTH PLANNING, LLC removed 2,317,589 shares (-99.6%) from their portfolio in Q3 2026, for an estimated $509,707,348
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$IBM Government Contracts
We have seen $1,174,906,546 of award payments to $IBM over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- BENEFITS TRANSFORMATION PLATFORM: $134,809,706
- SUSTAINMENT, ENHANCEMENT AND TRANSITION SUPPORT OF VAS ENTERPRISE CORE HR SOLUTION - HRSMART. THE CONTRACT...: $73,015,790
- DEVELOPMENT, SECURITY, AND OPERATIONS (DEVSECOPS) SERVICES TO SUPPORT UNITED STATES CITIZENSHIP AND IMMIGRA...: $65,151,545
- NAVY ENTERPRISE RESOURCE PLANNING (ERP) TECHNICAL SUPPORT SERVICES (NETSS).: $48,248,428
- MODERNIZED E-FILE (MEF): $46,814,864
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
$IBM Congressional Stock Trading
Members of Congress have traded $IBM stock 14 times in the past 6 months. Of those trades, 5 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $IBM stock by members of Congress over the last 6 months:
- REPRESENTATIVE PETE SESSIONS sold up to $15,000 on 10/20.
- REPRESENTATIVE LLOYD DOGGETT has traded it 2 times. They made 2 purchases worth up to $30,000 on 09/10, 06/10 and 0 sales.
- REPRESENTATIVE MARIA ELVIRA SALAZAR has traded it 6 times. They made 2 purchases worth up to $100,000 on 05/21 and 4 sales worth up to $60,000 on 09/04, 08/24.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 08/18 and 1 sale worth up to $15,000 on 07/17.
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 07/16, 07/15.
- REPRESENTATIVE MATTHEW VAN EPPS sold up to $15,000 on 06/16.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$IBM Analyst Ratings
Wall Street analysts have issued reports on $IBM in the last several months. We have seen 9 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 10/22/2026
- Citigroup issued a "Buy" rating on 10/22/2026
- Barclays issued a "Overweight" rating on 10/22/2026
- RBC Capital issued a "Outperform" rating on 10/22/2026
- JP Morgan issued a "Overweight" rating on 10/22/2026
- Stifel issued a "Buy" rating on 10/22/2026
- Argus Research issued a "Buy" rating on 07/16/2026
To track analyst ratings and price targets for $IBM, check out Quiver Quantitative's $IBM forecast page.
$IBM Price Targets
Multiple analysts have issued price targets for $IBM recently. We have seen 18 analysts offer price targets for $IBM in the last 6 months, with a median target of $267.0.
Here are some recent targets:
- Brent Thill from Jefferies set a target price of $280.0 on 10/22/2026
- Matthew Swanson from RBC Capital set a target price of $270.0 on 10/22/2026
- Rob Oliver from Baird set a target price of $260.0 on 10/22/2026
- David Vogt from UBS set a target price of $243.0 on 10/22/2026
- David Grossman from Stifel set a target price of $260.0 on 10/22/2026
- Brian Essex from JP Morgan set a target price of $269.0 on 10/22/2026
- James Friedman from Susquehanna set a target price of $256.0 on 10/22/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.